What are the potential interactions between Humacology 0:110 CBD Isolate 'YELLOW' Pastilles and Humacology 'BLACK' 0:250:60:20 Broad Spectrum CBD+CBN+CBC Oil in a patient taking Frixor (fluoxetine) and Ritalin (methylphenidate)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

I strongly advise against combining CBD products with Effexor (venlafaxine) and Ritalin (methylphenidate) without consulting a healthcare provider due to potential unpredictable interactions and increased risk of adverse effects, as highlighted in studies such as 1 and 1. When considering the two Humacology products, the "BLACK" 0:250:60:20 Broad Spectrum option containing CBD, CBN, and CBC may provide more comprehensive effects due to the entourage effect from multiple cannabinoids, compared to the "YELLOW" CBD Isolate Pastilles which contain only pure CBD. The broad spectrum formula might better address multiple symptoms like anxiety, pain, and sleep issues. However, these cannabinoids could potentially interact with your medications by affecting the same liver enzymes (CYP450) that metabolize Effexor and Ritalin, possibly increasing side effects or altering their effectiveness, as noted in 1. Some key points to consider when combining these substances include:

  • Starting with a low dose of either product, preferably under medical supervision
  • Monitoring for changes in your medication effects or new side effects like increased drowsiness, changes in blood pressure, or mood alterations
  • Separating the timing of doses from your prescription medications by at least 2 hours to minimize potential interactions, as suggested by the principles outlined in 1
  • Being aware of the potential for serotonin syndrome when combining serotonergic medications, as warned in 1 It is crucial to prioritize caution and consult with a healthcare provider to ensure safe and effective management of your medications and CBD products, given the potential risks and interactions highlighted in studies like 1 and 1.

From the Research

Comparison of Humacology Products

  • Humacology 0:110 CBD Isolate "YELLOW" Pastilles and Humacology "BLACK" 0:250:60:20 Broad Spectrum CBD+CBN+CBC Oil have different compositions and potential effects.
  • The "YELLOW" Pastilles contain CBD isolate, which has been shown to have anxiolytic and anti-depressive effects in low doses 2.
  • The "BLACK" Oil is a broad spectrum product containing CBD, CBN, and CBC, which may have additional effects due to the presence of minor cannabinoids.

Interaction with Prescription Medications

  • When considering the use of these products with prescription medications like frxxor and Ritalin, it is essential to examine potential interactions.
  • Ritalin (methylphenidate) is a psychostimulant that can be used to treat attention-deficit hyperactivity disorder (ADHD) and may be combined with selective serotonin reuptake inhibitors (SSRIs) like fluoxetine for comorbid conditions 3, 4.
  • The combination of methylphenidate and fluoxetine has been shown to have anxiolytic and anti-depressive effects in adolescent rats 4.
  • However, there is limited research on the interaction between CBD, CBN, CBC, and these prescription medications.

Effects of Minor Cannabinoids

  • CBN has been claimed to have sleep-promoting effects, but there is insufficient clinical evidence to support this claim 5.
  • CBC and CBN have been shown to have anti-inflammatory effects in human macrophages, which may be beneficial for various disorders 6.
  • The anti-inflammatory effects of these minor cannabinoids may be influenced by their interaction with the endocannabinoid system and other cellular pathways.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.